BRAIN Biotech AG (0RFI.L)
LSE - LSE Delayed price. Currency in EUR
Add to watchlist
As of 01:11PM BST. Market open.
| Previous close | 2.8845 |
| Open | 0.0000 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 9,584 |
| Market cap | 506,562 |
| Beta (5Y monthly) | 1.28 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.3690 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.BRAIN Biotech AG's (ETR:BNN) Intrinsic Value Is Potentially 42% Above Its Share Price
Key Insights BRAIN Biotech's estimated fair value is €4.42 based on 2 Stage Free Cash Flow to Equity BRAIN Biotech's...
- Simply Wall St.
Investors in BRAIN Biotech (ETR:BNN) have unfortunately lost 63% over the last five years
Generally speaking long term investing is the way to go. But along the way some stocks are going to perform badly. For...
Simply Wall St.BRAIN Biotech First Quarter 2024 Earnings: €0.12 loss per share (vs €0.12 loss in 1Q 2023)
BRAIN Biotech ( ETR:BNN ) First Quarter 2024 Results Key Financial Results Revenue: €13.1m (down 6.3% from 1Q 2023...
© 2024 Yahoo. All rights reserved.